TrialJournal of acquired immune deficiency syndromes (1999)2016

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

Maile Y Karris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.